BCR and B-cell chronic lymphocytic leukemia: To evaluate the effect of TG02 under the protective environments in lymph nodes, we cultured the CLL cells with goat F(ab’)2 fragment to human IgM (anti-IgM) to crosslink BCR to mimic its in vivo activation in lymphoid tissue.